Pharma VC Funds

Endure Capital, founded in 2015 by Tarek Fahim, is an early-stage investment fund based in Cairo, Egypt. The firm focuses on investing in startups across various sectors, including technology, healthcare, fintech, and foodtech. With an asset under management (AUM) of $85 million, Endure Capital has invested in 52 companies and has had significant exits, including Careem, which was acquired by Uber for $3.1 billion. The firm's notable investments include regional leaders like MaxAB, a B2B e-commerce platform, and Breadfast, a pioneering grocery delivery startup. Internationally, their portfolio features companies like Boom Supersonic and Aspect Biosystems. Endure Capital typically invests in pre-seed, seed, Series A, and Series B rounds, with ticket sizes ranging from $1 million to $5 million. Endure Capital recently closed the first round of its $50 million fund, Endure 21, aimed at impact-driven early-stage startups in Africa and selectively investing in growth-stage startups globally. The firm is expanding its reach into North America and Saudi Arabia, launching the Arak Fund in partnership with Awaed Capital, which focuses on various advanced sectors including space technology and AI infrastructure. Endure Capital also emphasizes long-term support and mentorship for its portfolio companies through initiatives like “Endure... Pay it Forward,” reflecting its commitment to nurturing a vibrant startup ecosystem.

Eniac Ventures is a premier seed-stage venture capital firm with a notable portfolio including Hinge, Headspace, and Tapad. Focused on AI, SaaS, healthcare, and deep tech, Eniac invests primarily in U.S.-based companies. The firm typically leads seed rounds with average check sizes ranging from $500K to $1M, and is renowned for its hands-on approach and strategic support. Co-founders Hadley Harris and Nihal Mehta leverage their extensive entrepreneurial backgrounds to guide startups towards success. Eniac prefers pitches that demonstrate strong technical foundations and significant market potential. They have been especially active recently, seeking bold, transformative startups that can redefine their industries. For founders, a warm introduction and a well-prepared, concise pitch are key to gaining their attention. Eniac’s team is dedicated to fostering innovation and driving growth, positioning themselves as valuable partners in the startup ecosystem.

Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.

Entrée Capital, a global venture capital firm founded in 2010, provides multi-stage funding for innovative startups from pre-seed to growth stages. They manage over $1.25 billion across nine funds, focusing heavily on fintech, deep tech, SaaS, AI, blockchain, and e-commerce sectors. Their notable investments include Monday.com, Coupang, Stripe, and Cazoo. Based in Tel Aviv, Israel, with additional offices in London and New York, Entrée Capital primarily targets investments in Israel, the U.S., and Europe. The firm’s strategy involves supporting startups from the idea stage through to scaling, providing both capital and strategic guidance. They actively lead funding rounds and offer extensive mentorship and market insights to help portfolio companies navigate growth challenges. Key team members include Aviad Eyal, co-founder and managing partner, and Eran Bielski, general partner. Both bring extensive experience in venture capital and entrepreneurship, contributing to the firm's strong track record of successful investments and exits. Entrée Capital has backed over 180 startups, achieving more than 27 exits and IPOs, and supporting over 17 unicorns. The firm’s approach emphasizes building strong, long-term relationships with founders and aligning closely with their visions. They are particularly accessible through direct contact on their website and prefer pitches that demonstrate clear, innovative business models and strong market potential.

Entrepreneur First (EF) is a global talent investor founded in 2011 by Alice Bentinck and Matt Clifford. EF's unique approach focuses on helping individuals build technology companies from scratch, often before they have a team or specific idea. This model emphasizes selecting ambitious individuals based on their potential and providing them with the resources to find co-founders and develop their startups. Operating in major cities such as London, Singapore, Berlin, Paris, Bangalore, and Toronto, EF has successfully created over 500 companies with a combined valuation exceeding $10 billion. Some of their most notable investments include Tractable, a computer vision company valued at $1 billion; Magic Pony Technology, which was acquired by Twitter for $150 million; and Omnipresent, a remote HR platform. EF typically invests around £80,000 in each startup in Europe, C$100,000 in Canada, and SG$75,000 in Asia, in exchange for a 10% equity share. Their portfolio boasts significant exits like Deliveroo, PassFort Limited, and Trussle, showcasing their effectiveness in nurturing early-stage startups. EF's investment philosophy prioritizes talent over pre-existing ideas, enabling them to partner with ambitious individuals early in their entrepreneurial journey. The firm has received backing from prominent figures and institutions, including Reid Hoffman, co-founder of LinkedIn, and John and Patrick Collison, co-founders of Stripe. This strong support system, coupled with EF's robust program, helps founders develop their ideas, find co-founders, and secure further investment from top-tier venture capital firms.

Entrepreneurs Roundtable Accelerator (ERA), founded in 2011, is New York City's leading technology accelerator and early-stage venture capital fund. ERA focuses on investing in startups at the forefront of various industries, including health care, financial services, future of work, commerce, and climate. ERA typically invests $150,000 in each company for a 6% stake through a post-money SAFE. The accelerator provides extensive support to its portfolio companies, including free office space, cloud hosting credits, and access to a network of over 1,000 expert mentors. This mentorship network is crucial in helping startups navigate the challenges of early-stage growth. Notable investments by ERA include Glia, TripleLift, Katapult, Thirty Madison, Nayya, Order, Bespoke Post, User Interviews, Fund That Flip, CardFlight, and Scentbird. ERA alumni companies have collectively raised over $2 billion in investor capital and exceed $10 billion in market capitalization. ERA is known for its robust support system, which includes talent acquisition, business development, community and networking, marketing, and PR. The accelerator's commitment to fostering innovation and entrepreneurship has positioned it as a pivotal player in New York's startup ecosystem​.

EPIC Ventures, based in Salt Lake City, Utah, is a venture capital firm that specializes in early-stage investments in technology sectors such as SaaS, healthcare, security, and fintech. Founded in 1994, EPIC Ventures has a long history of backing companies that are innovating in emerging markets. Some of their notable portfolio companies include Recursion Pharmaceuticals, Medsphere, and Health Catalyst, showcasing their strong focus on health and life sciences. The firm is also active in sectors like future of work and AI, with investments in xAI and Unlearn.AI. EPIC Ventures is known for its hands-on approach, providing not just capital but also strategic guidance and access to an extensive network of advisors. They work closely with the University of Utah through a joint venture called University of Utah Ventures, which focuses on supporting startups and commercialization efforts from academic research.

Epidarex Capital is a dynamic venture capital firm focusing on early-stage life science investments in under-ventured research hubs across the US and UK. The fund targets transformative opportunities in biotechnology, pharmaceuticals, medical devices, and health tech. Notable investments include Dunad Therapeutics, EM Imaging, and Leucid Bio. Established in 2010, Epidarex partners with leading universities and research institutions, providing crucial capital to spin out innovative technologies with the potential for significant patient impact and high financial returns. Their investment strategy prioritizes disruptive platform technologies addressing unmet medical needs, robust intellectual property portfolios, and early evidence of market validation. Epidarex is known for backing driven and tenacious founders, often providing seed or Series A funding. They maintain a rigorous evaluation process to ensure each investment has a sustainable competitive advantage and clear regulatory strategies. Epidarex's team, led by General Partner Elizabeth Roper, boasts extensive experience in the life sciences and venture capital sectors. Roper, with a background at The Wellcome Trust and Atlas Ventures, plays a pivotal role in shaping early-stage opportunities into successful companies. For startups looking to partner with Epidarex, it's crucial to demonstrate strong scientific foundations, clear commercialization pathways, and the potential for outstanding financial returns and patient benefits​.

Episode 1 Ventures, based in London, specializes in early-stage investments in technology companies across the UK. Founded in 2013, the firm focuses primarily on B2B software sectors, including AI, health tech, and software infrastructure. Their portfolio boasts notable investments such as Carwow, Triptease, and AimBrain. Episode 1 Ventures has recently launched a £76 million investment fund to support the next generation of tech startups. This fund is their largest yet and aims to provide substantial support to early-stage B2B firms, reflecting their commitment to fostering innovative UK-based companies​. The firm’s investment strategy typically involves making initial investments ranging from £250,000 to £3 million, guiding startups towards successful Series A rounds. They emphasize a hands-on approach, providing operational expertise and strategic guidance to help startups scale​. Key team members include Simon Murdoch, Adrian Lloyd, and Damien Lane, who bring extensive experience in entrepreneurship and investment. Their combined expertise ensures that Episode 1 Ventures can offer not just financial support, but also valuable mentorship and industry insights to their portfolio companies.

EQT Ventures is a powerhouse in the venture capital world, renowned for its robust investment portfolio and strategic prowess. The fund, managing €1.1 billion, focuses on early-stage tech startups, primarily in Europe and North America. Notable investments include Wolt, Peakon, and Airkit, showcasing its knack for backing high-potential companies. EQT Ventures targets industries like fintech, health tech, AI, mobile gaming, and sustainability. The fund is particularly interested in business models with scalable tech solutions that address real-world problems. Geographically, EQT Ventures has a strong presence in Europe and the US, with offices in major hubs like Stockholm, London, Berlin, Paris, and San Francisco. This broad reach helps them tap into diverse markets and innovation ecosystems. Their investment strategy is both aggressive and supportive, offering initial investments ranging from €1 to €50 million. EQT Ventures is known for its active involvement in scaling startups, leveraging a team of over 40 founders and operators. The advisory team, split equally between men and women, uses proprietary AI tools like Motherbrain to identify and nurture high-growth opportunities. Founders can expect a hands-on approach, with EQT Ventures providing not just capital, but also strategic guidance and operational support. The team, led by key figures like Lars Jörnow and Ashley Lundström, brings a wealth of experience and a track record of success in building global companies.

Equilibrium Capital is a sustainability-focused asset management firm, founded in 2008 with the mission to drive sustainable prosperity through capital markets. The firm is dedicated to investing in sustainable real assets, with a focus on two key sectors: sustainable food and agriculture, and carbon transition infrastructure. Equilibrium is committed to building investment portfolios that not only generate financial returns but also create positive environmental and societal impacts. The firm’s investment strategies are built on proprietary research, aiming to capture value from sustainability trends such as climate adaptation, net-zero goals, and changing consumer patterns. Equilibrium’s portfolio includes diverse investments that target resilience, resource efficiency, and sustainable business models in sectors that are reshaping the future. With a global presence, including offices in San Francisco, Portland, Singapore, and London, Equilibrium serves institutional investors by providing innovative and scalable sustainability-driven financial products. The firm is led by CEO and founder Dave Chen, who has a strong background in venture capital and sustainability finance.

Esco Ventures, the investment arm of Singapore-based Esco Group, focuses on early-stage life sciences and medtech startups. The firm specializes in areas like biotech, diagnostics, and women’s health, aiming to nurture groundbreaking technologies that improve global health. What sets Esco Ventures apart is its hands-on approach, offering startups more than capital by providing mentoring, productization, manufacturing support, and global distribution networks through its parent company, Esco Group. Esco Ventures plays a crucial role in shaping the next wave of medical innovations, drawing on Esco Group’s decades of experience in life sciences. Their investment philosophy is built around long-term growth, with an emphasis on addressing unmet medical needs through disruptive technologies. The firm has a global reach but maintains a particular focus on Singapore, aligning with the nation’s vision to become a biomedical innovation hub in Asia. Under the leadership of Managing Partner XiangQian Lin, Esco Ventures works closely with scientists, engineers, and entrepreneurs, guiding them from ideation to commercialization. The firm has already seen success with investments like a Danish/Lithuanian medical device company, which achieved 5x growth within three years. Esco Ventures also actively supports the local Singaporean ecosystem by mentoring early-stage researchers and startups even before formal incorporation, fostering a collaborative and innovative environment aimed at creating the next big breakthroughs in life sciences and medtech.

Eurazeo is a prominent global investment group with approximately €35 billion in assets under management, including €24 billion managed on behalf of institutional and private clients. The firm specializes in private equity, private debt, and real assets, with investments spanning consumer, healthcare, tech-enabled services, and financial services sectors. Notable investments include high-profile companies like Moncler, Farfetch, Vestiaire Collective, Asmodee, and Orolia, as well as tech companies like Deezer and Onfido. Eurazeo’s strategy focuses on identifying and accelerating the growth potential of their portfolio companies through capital investment and strategic support. Eurazeo operates across various investment strategies, including buyouts, growth capital, venture capital, and real assets. With offices in Europe, North America, and Asia, Eurazeo has a diverse geographic reach and is committed to long-term value creation with a responsible investment approach.

Eureka! Venture SGR, established in 2019, is Italy's first independent venture capital firm focusing exclusively on deep tech investments. Based in Milan and Rome, Eureka! specializes in transformative technologies, including AI, energy, health and well-being, mobility, and environmental innovations. The firm manages Eureka! Fund I, a technology transfer fund designed to bridge the gap between scientific discovery and commercial success. With a focus on startups born from cutting-edge research, Eureka! aims to foster the development of deep tech solutions that have the potential to revolutionize industries. Their portfolio includes startups like BeDimensional (nanotechnology) and ReHouseIt (sustainable construction), reflecting their commitment to impactful innovation. Eureka! also adheres to strict ESG (Environmental, Social, Governance) principles, aligning their investments with the UN's 2030 Sustainable Development Goals. The firm’s leadership, including CEO Stefano Peroncini and co-founder Anna Amati, brings over 25 years of experience in venture investing and technology transfer. This expertise enables them to guide startups from initial innovation to market, leveraging strategic partnerships with universities and research institutions across Europe. In addition to deep tech, Eureka! operates the BlackSheep Fund, which invests in late-stage European tech companies transforming the marketing industry through AI and big data.

The European Circular Bioeconomy Fund (ECBF) is a specialized venture capital fund dedicated to driving the transition from a fossil-based to a bio-based economy in Europe. Established in 2020 and headquartered in Luxembourg, ECBF was initiated with support from the European Union to fill a critical funding gap identified in the growth phase of bioeconomy companies. The fund, managed by Hauck & Aufhäuser Funds Services S.A. and advised by ECBF Management GmbH, has raised €300 million, surpassing its initial target of €250 million. ECBF focuses on investing in growth-stage companies that contribute to the circular bioeconomy, aiming to support innovative entrepreneurs whose technologies can revolutionize industries and promote sustainability. The fund's portfolio includes companies across various sectors such as bio-based materials, agritech, and bioplastics. ECBF's investments align with the European Green Deal goals, particularly the aim to make Europe climate neutral by 2050. The fund's approach combines financial support with strategic guidance, leveraging a diverse and experienced team to help portfolio companies achieve both environmental impact and favorable financial returns. Investors in ECBF include a mix of public and private entities from across Europe, reflecting broad support for advancing the bioeconomy sector.

Evolution VC Partners is a New York-based venture capital firm focused on "culture-tech" investments—companies that are reshaping how people work, live, and interact with technology. Established by Gregg Smith, the firm primarily invests in sectors such as advanced materials, 3D printing, fintech, media, entertainment, digital health, life sciences, and plant-based innovations. Their goal is to support disruptive companies that are defining today's culture and paving the way for future societal shifts. The firm is stage-agnostic, meaning it invests in companies at various phases, from early-stage to growth-stage ventures. Evolution VC Partners works closely with founders, providing not just capital but also strategic advice to accelerate growth. Their portfolio includes notable companies like Instacart, Rodo, DailyPay, and Axiom Space. What sets Evolution apart is that it operates solely with the founder's personal capital, allowing for more flexibility and focus on long-term impact rather than external fund performance​.

Evolv Ventures is a venture capital firm based in Chicago, founded in 2018 by Kraft Heinz with a $100 million fund to invest in emerging technologies that are transforming the food industry. The fund is particularly focused on early-stage startups in sectors like food technology, retail technology, consumer products, and digital logistics. Evolv Ventures leverages Kraft Heinz’s extensive network, industry expertise, and resources to support the growth of its portfolio companies, positioning itself as a value-added investor in the food tech space. The firm is led by seasoned venture investor Bill Pescatello, who brings a wealth of experience from previous roles at Lightbank and GE Capital. Notable investments by Evolv Ventures include companies like New Culture, which is developing animal-free dairy products, and Zippin, a startup focused on checkout-free retail technology. By combining financial backing with strategic support, Evolv Ventures aims to drive significant innovation and disruption within the food industry, ultimately aligning with Kraft Heinz’s broader goals of staying at the forefront of food innovation.

Evonik Venture Capital, the corporate venture arm of Evonik Industries, manages a fund size of €400 million and has made over 50 investments since 2012. The firm strategically invests in innovative startups across various growth fields such as Nutrition & Care, Smart Materials, Specialty Additives, and Digitalization, with a strong focus on sustainability and carbon neutrality technologies​. Evonik's portfolio includes startups like Interface Polymers, which develops additives for easier recycling of plastics, and SuperC, a leader in graphene materials for improving lithium-ion batteries. Other notable investments are Allay Therapeutics, which has developed a post-surgery pain relief implant, and Citrine Informatics, an AI-driven platform for materials and chemicals development​. The venture capital unit emphasizes early to growth-stage investments, with typical investment volumes of up to €15 million per portfolio company. They aim to be an active partner, providing strategic, technical, and commercial support, and leveraging their extensive network for the growth of their portfolio companies. Evonik Venture Capital operates globally with offices in Germany, the USA, and China, making them well-positioned to support innovative startups in key regions worldwide.

Excalibur Group Holdings, based in London, is a venture capital firm with a strong focus on life sciences, biotechnology, and medical devices. Established in 1996, the firm has built a reputation for bridging the gap between research and commercialization, providing both early and late-stage capital. Excalibur plays an active role in developing cutting-edge therapies, diagnostics, and healthcare technologies. Their investment strategy targets companies that are innovating in critical areas such as oncology, therapeutic devices, and laboratory services. The firm has made over 59 investments, with notable companies like Celsis International, NeoGen, and Selah Genomics. Excalibur's investments span various stages, from early ventures to generating revenue, and their portfolio emphasizes transformative healthcare solutions. They have also facilitated numerous successful exits, including companies like Plethora Solutions and Celsis In Vitro. Excalibur's approach is highly strategic, supporting startups not just with capital but also by offering market access and strategic advice, positioning them for acquisitions or public listings. This makes Excalibur a critical player in the European life sciences venture space, known for its ability to take healthcare innovations from the lab to the marketplace.

Excell Partners is a prominent venture capital firm based in Rochester, New York. Established in 2006, it focuses on seed-stage investments, primarily targeting high-tech, high-growth startups in Upstate New York. Excell Partners is an affiliate of the University of Rochester and manages over $40 million in assets, having invested in 60 companies across various sectors including medical devices, materials, energy, biotech, agtech, imaging, and IT/software. Under the leadership of CEO Theresa Mazzullo, Excell Partners emphasizes a hands-on approach, providing not only capital but also extensive support through strategic guidance, a broad network of professionals, and long-term partnership commitments. Their investment strategy includes maintaining "dry powder" for follow-on funding to ensure continuous support for portfolio companies as they scale. Excell Partners also manages the $25 million Finger Lakes Forward Venture Capital Fund, which supports regional strengths in optics, imaging, photonics, food and agriculture, life sciences, and advanced manufacturing. This fund aims to boost economic growth in the Greater Rochester area by increasing access to capital for high-tech startups. Notable investments include RealEats, a prepared meal delivery service, and Owl Autonomous Imaging, which focuses on advanced thermal sensor technologies. Excell Partners is dedicated to fostering innovation and economic development in the Finger Lakes region, leveraging the area's academic and research strengths to nurture promising startups and retain local talent.

Exor N.V. is a prominent European investment company headquartered in Amsterdam, Netherlands, controlled by the Agnelli family. Established in 1927, Exor's portfolio is diverse, encompassing various industries such as automotive, luxury goods, media, and healthcare. Key holdings include significant stakes in well-known companies such as Ferrari, Stellantis, and CNH Industrial. Exor owns 22.9% of Ferrari, making it a crucial player in the luxury sports car market. Stellantis, one of the world's leading automakers, also forms a significant part of their portfolio with brands like Fiat, Chrysler, and Peugeot. CNH Industrial, involved in agricultural and construction equipment, is another major investment. In the media sector, Exor holds a substantial share in The Economist Group, owning 43.4% of its economic rights. They also have a significant investment in GEDI Gruppo Editoriale, a major Italian media conglomerate, holding 89.6% of the economic rights. Exor's investment strategy focuses on long-term value creation, often involving active participation in the management of their portfolio companies to drive growth and innovation. This approach is evident in their diversified and strategically selected investments across various sectors.

Expa, founded by Garrett Camp in 2013, is a venture studio and VC fund based in San Francisco. It focuses on early-stage investments, particularly in SaaS, FinTech, ClimateTech, E-Commerce, and software sectors. Notable investments include companies like Aero, Current, Collective, Metabase, and Joro. With over 100 investments and 11 exits, Expa typically provides seed funding between $500K and $1M and plays an active role in guiding startups through MVP development, hiring, and finding product-market fit. Expa’s strategy is centered around supporting founders with both capital and hands-on expertise. They value strong, innovative ideas and prefer to be approached with detailed, well-structured pitches demonstrating clear market potential. Their global reach includes significant investments across the U.S., with key operations in San Francisco​​. The Expa team, featuring industry leaders and experienced entrepreneurs, ensures robust support for their portfolio companies. For those looking to engage with Expa, networking through industry events and leveraging mutual connections can be effective ways to gain their attention.

Expansion Venture Capital, also known as Expansion VC, is a prominent early-stage venture capital firm focused on investing in pre-seed, seed, and select Series A stage technology companies. Founded by brothers Joseph and Ryan Melohn, the firm operates primarily out of New York City and Miami. Expansion VC's portfolio boasts a range of successful companies across various sectors, including notable investments in ClassPass, Turo, Carta, Lemonade, The RealReal, Allbirds, and Firebase. These investments span industries such as fintech, proptech, digital health, and consumer technology. The firm is known for its hands-on approach, providing not just capital but also strategic support in areas like mentorship, customer acquisition, talent sourcing, and securing partnerships. The firm prides itself on building long-term relationships with its founders, offering around-the-clock support to help navigate challenges and drive growth. Expansion VC has a reputation for leveraging its extensive network to accelerate the success of its portfolio companies by facilitating key introductions and securing strategic guidance.

ExSight Ventures is a New York City-based life sciences venture capital firm founded in 2014, specializing exclusively in early-stage ophthalmic diagnostic and treatment solutions. The firm was co-founded by James Murray alongside Dr. Michael Nissen, a retinal surgeon on faculty at Weill-Cornell Medical Center since 1998, and Dr. Firas Rahhal, also a retinal surgeon. The team of eight partners combines deep clinical domain expertise with investment and legal experience, including Murray's role as Chair of the Emerging Companies and VC Committee at the NYC Bar Association. ExSight raised its fourth fund in 2025, marking continuous growth since founding. The firm leads rounds and deploys checks from $250K to $4 million, investing from Seed through Series B in companies across North America. With 21 investments to date, notable portfolio companies include Horizon Surgical Systems, for which ExSight led a $30 million Series A in October 2024 in a robotics and AI surgical platform; ONL Therapeutics, which raised $65 million in a Series D alongside J&J Innovation; Re-Vana Therapeutics; Envision Diagnostics; Trefoil Therapeutics; LensGen; and Valitor Bio. Three portfolio companies have been acquired: DTx Pharma by Novartis, RetroSense Therapeutics by Allergan, and ELIOS Vision by Bausch & Lomb in December 2024. ExSight's thesis holds that ophthalmology is an ideal venture investment domain due to its massive and growing global market, insufficient current standards of care, a robust innovation pipeline, and the eye's unique anatomy as a proving ground for breakthrough technologies including gene therapy, AI diagnostics, and surgical robotics. The firm's clinical founders give it a differentiated vantage point for evaluating scientific merit, clinical feasibility, and commercial potential simultaneously.

Extantia Capital is a Berlin-based venture capital firm dedicated to accelerating decarbonization through early-stage investments in climate technology. With over €100 million in assets under management, Extantia focuses on scalable deep decarbonization solutions that have the potential to significantly reduce global carbon emissions. The firm employs a "carbon math exclusion principle," investing only in startups that can abate at least 100 million tonnes of CO2 annually when fully scaled. This strategy directs them towards hardware-based innovations in sectors such as energy, carbon removal, transportation, and industrial processes. Extantia operates through two main funds: Flagship, which backs transformative companies like INERATEC (e-fuels) and Reverion (biogas energy), and Allstars, which invests in other climate-focused venture funds. Their portfolio includes 12 companies, many of which focus on hard-to-abate sectors using technologies like direct air capture and green hydrogen production. The firm’s approach to building successful ventures is deeply rooted in strong founding teams, balancing technical expertise with commercial acumen. Extantia looks for co-founders who can work collaboratively across disciplines, ensuring that both the technological and business aspects of their startups are well-aligned. Looking forward, Extantia anticipates that the next generation of unicorns will emerge from the climate tech space. They are particularly excited about trends like green ammonia and the sustainable mining of raw materials, which are critical for the energy transition. Extantia is positioning itself at the forefront of this shift, creating opportunities for both significant climate impact and financial return.

F-Prime Capital is a global venture capital firm that focuses on investing in healthcare and technology. With roots tracing back to Fidelity Investments, F-Prime Capital has a long history of supporting innovative companies and fostering entrepreneurship. The firm has invested in over 290 companies across various stages and sectors, with notable investments in companies like Alibaba, Moderna, and Affinia Therapeutics. F-Prime Capital's investment portfolio spans a range of industries including therapeutics, enterprise IT, fintech, and medtech. For instance, Affinia Therapeutics is working on developing transformative gene therapies, while Alibaba is a major player in the e-commerce sector. The firm has also been involved in companies like Airespace, which was acquired by Cisco, and AlphaGen Therapeutics, focusing on radiopharmaceuticals. The firm's approach includes investing in early-stage companies and supporting them through their growth phases with both capital and strategic guidance. F-Prime Capital emphasizes the importance of innovation and has been a significant player in advancing new technologies and solutions within its focus areas.

F2 Venture Capital is a Tel Aviv-based venture capital firm focused on early-stage investments, particularly at the intersection of big data, artificial intelligence (AI), and connectivity. Founded to support visionary entrepreneurs, F2 backs startups from pre-seed through Series B, offering not just capital but also strategic guidance and operational support to help founders scale their businesses effectively. F2's portfolio is diverse, with investments in companies across sectors like AI, healthcare, and enterprise solutions. Some notable companies backed by F2 include Explorium, a data science platform, Parametrix, an AI-powered monitoring service for cloud infrastructure, and Justt, which provides fraud prevention for online transactions. F2 is also known for its deep involvement in Israel’s vibrant tech ecosystem and runs "The Junction," a pre-seed program designed to help startups grow from day one. With a strong focus on empowering founders, F2 Ventures combines its industry expertise and global network to help startups succeed in highly competitive markets. The firm operates with a "radically founder-focused" approach, ensuring personalized support for its portfolio companies at every stage of their development.

F7 Ventures is a pre-seed and seed-stage fund founded by seven seasoned female leaders from tech giants like Facebook, Google, and Yahoo. With a mission to support diverse founders, F7 Ventures emphasizes investments in sectors driving the future of work and consumer services. They are particularly drawn to entrepreneurs with deep operational experience, focusing on those building products that address significant societal shifts, like the growing digital workforce and consumer utility innovations. Key investments include startups like Fireflies.ai, an AI voice assistant for meetings, and Flockjay, an online sales academy. With a $50M Fund 1, F7 Ventures invests in building companies that can define the next decade. Geographically, they focus on Silicon Valley but also show interest in innovative founders globally. F7's strategy is hands-on, leveraging their vast operational network to guide founders through critical growth stages. They prefer leading investment rounds, offering deep tactical support through their Operator Network, which includes experts across recruitment, product, and growth strategy. They are selective in their investments, looking for tenacious founders with the potential to scale fast. Led by Kelly Graziadei and Joanna Lee Shevelenko, both former Facebook executives, F7 emphasizes diversity and community, helping founders build resilient, scalable companies with strong execution. Startups looking to approach F7 should emphasize their operational readiness and alignment with the fund’s focus on transformative, sustainable innovation.

Fall Line Capital, founded in 2011 and headquartered in San Mateo, California, specializes in investing in farmland and agricultural technologies. The firm combines expertise in venture capital with deep knowledge of agriculture to support innovative early-stage companies. Fall Line Capital’s portfolio includes notable investments in companies such as Impossible Foods, which produces plant-based meat substitutes; GreenLight Biosciences, focusing on RNA-based solutions for agriculture and human health; and Planet Labs, which provides satellite imagery for various applications. Other significant investments include FarmWise, known for its vision-based automation systems, and Trace Genomics, which offers soil diagnostics technology. The firm also actively manages farmland across the United States, leveraging this experience to add value to its tech investments by testing new products on their land. This unique strategy allows Fall Line to function both as a traditional venture investor and a strategic partner, providing a robust support system for their portfolio companies.

FST Ventures is a venture capital firm with a strong focus on early-stage investments in technology and fintech sectors. Founded by Victor Jiang, FST Ventures emphasizes a proactive management approach to mitigate investment risks. This involves securing board seats and getting actively involved in strategic and operational aspects of their portfolio companies, from cash flow management to strategic market entry and forming new partnerships. The firm's investment strategy is highly customer-centric, particularly in online marketplaces, where they prioritize informed self-service and robust cybersecurity measures. They aim to create a holistic value chain across their investments, ensuring comprehensive support and integration into the companies they back. FST Ventures is globally oriented, making strategic investments in diverse markets including North America, Europe, Asia, and Latin America. This geographic diversification allows them to dynamically allocate capital and resources based on market conditions and opportunities. Their portfolio includes investments in companies that leverage innovative technologies to disrupt traditional markets and create significant value. By focusing on sectors like business and financial services, healthcare, industrial, retail, and technology, FST Ventures aligns its investments with long-term growth and sustainability.

Felicis Ventures, based in Menlo Park, California, is renowned for backing transformative companies across various stages and sectors. Notable investments include Canva, Gusto, Guild Education, Komodo Health, and Matterport. They focus on frontier tech, health and bio, security, vertical SaaS, and AI. With a global investment approach, Felicis leads rounds and offers substantial support to founders. Their average check size varies but is known to be significant in leading investments. Key team members like Sundeep Peechu bring deep expertise from backgrounds in tech and venture capital. Approaching Felicis involves demonstrating high-risk, high-reward potential and a clear narrative aligning with their visionary outlook.

Felix Capital is a London-based venture capital firm that focuses on early-stage investments at the intersection of technology and creativity. Founded by Frederic Court, Felix Capital targets innovations that enable digital lifestyles, investing in brands and enabling technologies that cater to both personal and professional aspects of life. The firm's mission is to support entrepreneurs with big ideas and help them build strong, impactful brands​. Felix Capital manages over €1.2 billion across multiple funds, with its latest fund closing at over €562 million. This fund allows Felix to continue its strategy of backing culturally relevant consumer brands and enabling technologies, with a portfolio that includes notable companies like Mejuri, TravelPerk, SellerX, and Mirakl​. Felix Capital emphasizes a thematic and founder-centric approach, reinvesting in existing portfolio companies at key growth inflection points and exploring new areas such as Web3 and sustainable lifestyle solutions​. The team at Felix Capital is comprised of experienced investors and advisors, including new additions María Auersperg de Lera and Sophie Luck, who bring deep expertise to support the firm's vision and strategy​.

Fellows Fund is a venture capital firm established in 2021, with a focus on early-stage investments in artificial intelligence (AI) and related technologies. Headquartered in Sunnyvale, California, the fund has a mission to support next-generation AI startups by providing not just capital, but also strategic guidance and essential connections. Fellows Fund is led by Alex Ren, along with a team of distinguished fellows who are experts in fields like machine learning, AI infrastructure, and biotech. The fund's portfolio is diverse, including companies such as OmniML (acquired by Nvidia), Opus Clip, and Yoneda Labs, which are pushing the boundaries of AI applications across various industries. With investments ranging from $1 million to $10 million, Fellows Fund partners closely with founders to help them scale their businesses, leveraging the expertise of its team and a strong network within the AI community. The fund also emphasizes a collaborative approach, fostering a community of AI pioneers and thought leaders who contribute to the success of their portfolio companies.

ff Venture Capital (ffVC) is a New York-based venture capital firm, founded in 2008 by John Frankel and Alex Katz. The firm specializes in seed and early-stage investments across sectors such as AI, fintech, insurtech, drones, and robotics. With over 90 active portfolio companies, ffVC is known for its strategic investments and support for startups in emerging industries. Some of ffVC's notable investments include companies like Addepar, Cornerstone OnDemand, Indiegogo, Ionic Security, Skycatch, Plated, Owlet, and Socure. These investments highlight ffVC's focus on innovative technologies and their potential to transform industries. The firm typically invests with an average check size of over $500,000, leading or following in funding rounds to provide substantial support to its portfolio companies. ffVC has also expanded its operations globally, with a significant presence in Europe, particularly through its ff Red & White fund, which supports startups in Central Europe. This expansion demonstrates ffVC's commitment to driving innovation and supporting entrepreneurial ventures on an international scale. The firm places a strong emphasis on building a robust community around its investments, actively partnering with founders to create high-value, market-moving businesses. This approach is further strengthened by its strategic hires and collaborations, enhancing its operational capabilities and global reach.

Fifty Years is a pre-seed and seed-stage venture capital firm based in San Francisco. Founded in 2015 by Ela Madej and Seth Bannon, Fifty Years focuses on backing founders who leverage technology to solve some of the world’s biggest challenges, such as climate change, disease, and malnutrition. The firm has a strong mission-driven investment approach, supporting companies that aim to achieve significant societal impact while also being massively profitable. The firm's portfolio includes innovative companies like Upside Foods (cell-based meat), Solugen (decarbonizing the chemicals industry), and Opentrons (affordable robots for biologists). Fifty Years has invested in a variety of sectors including biotechnology, food technology, and advanced manufacturing. The leadership team is comprised of experienced entrepreneurs and investors, with Ela Madej bringing her extensive background as a serial tech entrepreneur and Y Combinator alum. Fifty Years emphasizes helping scientists and engineers become successful entrepreneurs, providing not only capital but also strategic guidance and support.

Fin Capital, established in 2018, is a distinguished global asset management firm dedicated to B2B fintech software. With a portfolio that spans pre-seed to IPO stages, Fin Capital has invested in over 120 active companies, including notable names like SoFi, Onfido, and Salt Labs​. Fin Capital focuses on various subsectors within the fintech space, such as next-gen banking and payments, asset management, capital markets, vertical AI, and insurtech. Their strategy revolves around partnering with repeat entrepreneurs who possess deep financial services experience and a global perspective. Fin Capital is renowned for its hands-on approach, often leading investment rounds and providing comprehensive support through growth stages. Geographically, Fin Capital operates globally with a strong emphasis on transformative financial services technologies. Their investment strategy includes initial checks across different growth stages and a robust commitment to ongoing support for portfolio companies, ensuring sustained growth and market leadership. The team at Fin Capital is composed of 23 experienced professionals who bring a wealth of knowledge and operational expertise to the table. This team is pivotal in identifying and nurturing high-potential fintech ventures, fostering innovation and efficiency across the financial technology landscape.

Findaway Adventures is a venture capital firm founded in 2019 and based in Vancouver, Washington. The firm specializes in seed-stage investments, focusing primarily on consumer products and services, particularly in the health and wellness sectors. Their portfolio includes innovative companies like Ora Organic, a provider of organic nutritional supplements, and Hustle Clean, a personal care brand. Led by Robert Craven, a seasoned executive with experience scaling brands like MegaFood and Garden of Life, Findaway offers more than just financial support. They work closely with startups to provide strategic guidance, operational expertise, and leadership coaching, helping companies grow sustainably. Their first fund is now fully deployed, and while they are not currently seeking new investments, they continue to support existing portfolio companies as they scale. Findaway is deeply committed to nurturing purpose-driven businesses, bridging the gap between early funding rounds and larger venture capital investments. Their hands-on approach helps young companies navigate the complexities of scaling, making them a valuable partner for startups with high-impact goals.

Finistere Ventures, founded in 2005 and based in Newport Beach, California, specializes in investing in agritech and foodtech sectors. The firm focuses on companies that drive innovation and sustainability in agriculture and food production. With a robust portfolio of 79 investments, Finistere Ventures has supported notable companies such as Plenty, an indoor vertical farming company, and Telesense, which specializes in IoT solutions for grain storage monitoring. Significant exits include Transcend Medical and ShopWell, highlighting the firm’s successful investment strategy in the agrifood tech space. Finistere Ventures participates in early to late-stage funding rounds, providing both capital and strategic support to help companies scale effectively. Led by co-founders Arama Kukutai and Spencer Maughan, Finistere Ventures has a global reach, leveraging partnerships in regions such as the U.S., Australia, Israel, New Zealand, and Canada. Their investments span various technologies aimed at improving efficiency and sustainability in the food and agriculture industries.

Finovam Gestion is a venture capital firm based in Villeneuve-d'Ascq, France, with a focus on investing in innovative small and medium-sized enterprises (SMEs) across sectors such as information technology, healthcare, biotechnology, agro-resources, and ecotechnologies. With €100 million under management, the firm actively targets startups in the Hauts-de-France, Grand-Est, and Bourgogne Franche-Comté regions. Finovam typically invests between €100,000 and €1.5 million in early-stage companies, ranging from pre-seed to Series A/B rounds. Their approach emphasizes supporting high-potential companies with innovative solutions, often working closely with local manufacturers, incubators, and research centers to identify promising opportunities. Recent notable investments include companies like Osiris Agriculture and Adeiz. The firm's team, led by Anthony Daccache and Marc Blondet, provides hands-on support to help portfolio companies scale and succeed in competitive markets. Finovam Gestion’s strong local network and close relationships with institutions like Bpifrance, along with other corporate partners, allow it to nurture the next generation of tech leaders in France.

Firebolt Ventures is a venture capital firm that focuses on early-stage investments, primarily in the technology sector. They concentrate on startups in areas like software, cloud infrastructure, and fintech. Founded in 2014, the firm is based in Palo Alto, California, and takes an active approach to support founders throughout the entire lifecycle of their companies. Their portfolio includes high-profile startups like Deel, Groq, and BetterUp, with several unicorns under their belt. Firebolt is known for leading rounds, particularly in the early stages, with a typical check size in the range of $500K to $5M. The firm is heavily data-driven, using an algorithmic approach to identify opportunities​. The team, led by Cherian Mathew and Vineet Buch, brings a strong network and deep industry expertise. Firebolt Ventures has been especially active in the U.S. market, with some global outreach, focusing on sectors like enterprise software and business productivity tools​.

First Analysis is a Chicago-based venture capital firm with a focus on technology-driven sectors like healthcare, environmental technology, and software-as-a-service (SaaS). Established in 1981, the firm has invested over $825 million across multiple funds. Their approach combines deep sector expertise with integrative research, allowing them to identify high-growth opportunities in their areas of specialization. The firm typically invests in early- to growth-stage companies with proven business models and demonstrable customer success. Their portfolio includes companies in a range of sectors, such as Sware (life sciences software), Stamus Networks (network security), and Dina (home-centered care coordination). First Analysis is not just a financial backer but an active partner, offering strategic support to help companies scale effectively. In addition to venture capital, First Analysis offers investment banking services, assisting companies with mergers, acquisitions, and other financial strategies. Their investment philosophy is centered on building long-term relationships with founders, helping to create sustainable industry leaders.

First Check Ventures, founded in 2020 and based in San Juan, Puerto Rico, is a venture capital firm specializing in early-stage investments across diverse industries including fintech, consumer finance, internet retail, and human capital services. The firm was founded by Ali Jamal, who brings extensive experience as a serial entrepreneur and angel investor. First Check Ventures has invested in 100 companies and achieved 12 exits. Notable investments include companies like Lemonade, Finblox, and Bits Crypto. The firm focuses on providing not only capital but also mentorship, network, and guidance to its portfolio companies to help them achieve their full potential. They typically invest in the seed stage, supporting startups with promising and innovative ideas that have the potential to make a significant impact. The investment team includes founding partner Ali Jamal and partner Adwait Walimbe. Their approach is characterized by a strong commitment to backing passionate founders and fostering growth in their chosen industries.

FirstIn Ventures, based in the United States, focuses on early-stage investments in security technology sectors, particularly cybersecurity, defense, and data intelligence. Their mission is to back entrepreneurs who are dedicated to securing freedom through advanced technological solutions, leveraging their expertise as former operators and founders. Founded by Renny McPherson, Arthur Karell, and Lenore Karafa, the firm prides itself on supporting startups that offer innovative solutions in the security domain. Notable investments include companies like Adlumin, Castelion, Shift5, and Anduril, which are making significant strides in cybersecurity and defense technologies. FirstIn Ventures aims to be the premier early-stage security technology investment firm, helping portfolio companies with operational guidance and strategic insights. The firm values shared missions and domain expertise, making it a preferred partner for technical experts with backgrounds in commercial, military, or intelligence sectors.

First Round Capital, founded in 2004 and based in San Francisco, is a venture capital firm that specializes in seed-stage investments. The firm has an impressive track record, having supported over 300 startups across various sectors. Notable investments by First Round Capital include companies like Uber, Square, Warby Parker, Notion, Roblox, and Blue Apron. These companies have grown to become industry leaders, showcasing First Round's ability to identify and nurture high-potential startups from their earliest stages​​. First Round Capital's investment philosophy emphasizes building a strong community among its portfolio companies. They provide extensive support beyond just financial backing, including strategic guidance and access to a network of experienced founders and industry experts. Their average initial investment ranges from $1 million to $5 million, with a focus on being the lead investor in most cases. However, they also collaborate with other seed-stage VCs and angels​​. The firm primarily invests in companies based in the United States, with a few exceptions for companies in Canada. They have a hands-on approach, working closely with founders to help them navigate the challenges of building and scaling their businesses. First Round's unique platform and dedicated team of experts provide invaluable resources to help startups succeed​.

First Star Ventures, founded in 2014 and based in Cambridge, Massachusetts, is an early-stage venture capital firm. Co-founded by Drew Volpe and Millie Liu, the firm focuses on investing in disruptive technologies with a global impact. Their investment strategy targets sectors such as artificial intelligence, computational biotechnology, connected sensors, augmented reality, virtual reality, and blockchain. First Star Ventures has managed multiple funds, including their recent First Star Venture Fund III. They have made significant investments in innovative companies like Bedrock Energy, Salient, and Swiftly, emphasizing their commitment to transformative technologies. The firm typically partners with visionary founders, providing both capital and strategic guidance to help startups scale effectively. The team at First Star Ventures brings extensive experience in both founding and operating tech companies, which they leverage to support their portfolio companies. Their investments are characterized by a focus on early-stage, high-growth potential ventures, aiming to be the first institutional investor in these businesses.

Firstminute Capital is a London-based venture capital firm founded in 2017 by Brent Hoberman and Spencer Crawley. The firm manages $400 million in assets and focuses on seed-stage investments in the UK, Europe, and the US. Firstminute Capital aims to be the first check into a company, typically investing between £1 million and £3 million, and strives for a 10% ownership stake in each portfolio company. The firm is backed by over 130 unicorn founders and has invested in more than 150 companies across various sectors, including deep tech, AI, gaming, media, SaaS, and healthtech. Notable portfolio companies include Wayve, Mistral, Storyblok, and Taktile. Firstminute Capital's team comprises experienced entrepreneurs and investors, including co-founders Brent Hoberman and Spencer Crawley, who have founded and exited two unicorn startups and backed nine unicorns at the seed stage. The team also includes partners Lina Wenner and Sam Endacott, and principal Michael Stothard, among others. The firm emphasizes a strong community and network to support their portfolio companies, offering strategic guidance and leveraging connections to help startups achieve significant growth. Firstminute Capital's mission is to be Europe's most helpful seed fund, providing founders with comprehensive support from day one.

Hearst Ventures, established in 1995, is the corporate venture capital arm of Hearst Communications. Based in New York, it operates globally with offices in London, Beijing, and Tel-Aviv. Hearst Ventures has invested over $1 billion to date, making it one of the most active corporate venture funds. The firm focuses on early-stage investments in technology-driven businesses across various sectors, including media, information services, and technology. Notable portfolio companies include Via, a global provider of on-demand transit solutions; Roku, a leading streaming platform; and BuzzFeed, a prominent digital media company. Hearst Ventures has made a total of 199 investments and achieved 84 successful exits, including high-profile companies like Pandora and Brightcove. The leadership team at Hearst Ventures includes Kenneth Bronfin, Senior Managing Director and Head of International Investments; Scott English, Senior Managing Director and Head of U.S. Investments; and Darcy Frisch, Managing Director and Vice President. Their extensive experience and strategic guidance play a crucial role in driving the success of Hearst Ventures' portfolio companies.

has built a vast portfolio, including notable investments in companies such as Alibaba, Coupang, Flexport, Delivery Hero, Shipbob, Properly, Wallapop, and Rappi. The firm is known for its stage-agnostic approach, meaning they invest in companies at various stages, from pre-seed to later stages​​. FJ Labs focuses on identifying and supporting visionary founders who exhibit passion, grit, and the ability to execute their visions. Their investment strategy leverages their deep expertise in marketplaces, resulting in over 30 of their portfolio companies achieving unicorn status (valuations over $1 billion). With more than 1,000 investments, FJ Labs has made significant contributions to the startup ecosystem, particularly in sectors like e-commerce, logistics, and fintech​. The firm recently announced $260 million in new funds to continue its support of early-stage and growth-stage startups. This includes a pre-seed fund and an opportunity-style “Series B and beyond” fund, reflecting their commitment to nurturing startups through various growth phases​.

Flagship Pioneering is a prominent venture capital firm that specializes in biotechnology and life sciences. Based in Cambridge, Massachusetts, Flagship Pioneering both funds and incubates companies, creating transformative bioplatforms that address critical challenges in human health and sustainability. The firm has been instrumental in the development of groundbreaking companies like Moderna, Indigo Agriculture, and Generate. Founded by Noubar Afeyan, Flagship Pioneering operates with a robust capital pool, recently raising $3.6 billion to fuel innovations. This funding supports the development of first-in-category ventures, emphasizing the firm's commitment to pioneering new scientific discoveries and therapeutic advancements. Flagship's strategy involves a rigorous process of ideation, incubation, and scaling, working closely with scientific entrepreneurs to turn disruptive ideas into market-leading companies. Their focus areas include drug discovery, genetic medicine, agricultural technology, and sustainability solutions. The firm’s portfolio is extensive, with over 100 companies founded under its umbrella. Notable recent initiatives include collaborations with major pharmaceutical companies and the expansion into international markets, including new hubs in the UK and Asia-Pacific​

Flat6Labs is the MENA region’s premier seed and early-stage venture capital firm, fostering innovation across the Middle East and Africa. Known for its extensive startup programs, Flat6Labs invests in over 100 tech-driven startups annually, with notable investments in sectors such as HealthTech, FinTech, EdTech, GreenTech, and AgriTech. Key portfolio companies include Paymob, Instabug, and Elves. Flat6Labs operates with a strong geographic focus on North Africa, West Africa, and East Africa, expanding its impact through initiatives like the $95 million Africa Seed Fund. This fund aims to support 160 early-stage startups, focusing on digital inclusion and addressing social and environmental challenges. The firm’s investment strategy involves seed funding ranging from $150,000 to $500,000, typically leading investment rounds. Startups benefit from robust regional business support, access to a vast network of mentors, and logistical assistance. Flat6Labs runs multiple programs, including the Ignite Program in the UAE and the Anava Seed Fund in Tunisia, emphasizing a hands-on approach to nurturing entrepreneurial talent. The leadership team includes Ramez El-Serafy (CEO) and Dina El Shenoufy (CIO), both of whom bring extensive experience and strategic vision to the firm. Flat6Labs' holistic support and regional expertise make it a cornerstone in the MENA startup ecosystem, committed to driving long-term positive change and economic empowerment. This founder-friendly VC fund is not just about financial investment but also about building a supportive community that helps startups scale efficiently and sustainably.